The Formulary System in the Republic of Kazakhstan in 2012–2014
Abstract
The formulary system is a drug supply management method promoting drugs with proved efficiency, safety and cost-effectiveness. It is a regulatory tool for effective, safe and economically feasible drug supply in the public health sector in many developed countries (the UK, the US and other) as well as in developing countries. The study objective is the analysis of the Formulary System in primary and secondary healthcare settings in 15 regions of the Republic of Kazakhstan in 2012–2014. The study involved a survey of healthcare institutions via e-mail with a unified questionnaire containing evaluation indicators. The collected data was aggregated in an Excel spreadsheet. The study findings showed the 3 year dynamics of the Formulary system in the Republic of Kazakhstan, though did not specify the causes of irrational drug use. Ключевые слова. Формулярная система, рациональное использование лекарственных средств, клиническая фармакология.
About the Author
G. K. Zhussupova
I.M. Sechenov First MSMU
Kazakhstan
Kazakhstan
Gulzira K. Zhussupova, Postgraduate student, Scientific Research Institute of Public Health and Healthcare Management
Оffice 505, 8, Orynbor str., Astana, 010000
References
1. WHO. Promoting Rational Use of Medicines: Core Components. WHO Policy Perspectives on Medicines. 2002; September; 005. Available at: http://apps.who.int/medicinedocs/en/d/Jh3011e/1.html (accessed March 3, 2017).
2. “Densaulyk” for the 2016–2019 years State Health Development Program of the Republic of Kazakhstan”, approved by the Kazakhstan Republic President’s Decree № 176, on January 15, 2016 (in Russian).
3. Mushanova Z.E., Zhussupova G.K., Ihambaeva A.N. et al. Formulary System – The main Tool of Rational Drug Use. Guidelines. 2012 (in Russian).
4. Mazhitov T.M., Ahelova S.L., Karabaeva R.Z. Formulary system in the Republic of Kazakhstan. In: Materials of scientific-practical conference with international participation “Achievements of clinical pharmacology in Russia ”. 2009; 6: 92–93 (in Russian).
5. WHO. Guidelines for National Drug Policies. Geneva: World Health Organization. 1988.
6. MSH/RPM. Rapid pharmaceutical management assessment: an indicator-based approach. Washington DC: Management Sciences for Health, Rapid Pharmaceutical Management Project. 1995.
7. The Order of the Minister of Healthcare of Kazakhstan dated November 23, 2009 № 762 “On Approval of Rules of development and approval of medicinal forms of healthcare organizations” (in Russian).
8. Order of Acting Minister of Healthcare of Kazakhstan dated December 12, 2013 № 723 “On Approval of the Formulary Committee of the Republic of Kazakhstan Ministry of Healthcare” (in Russian).
9. Order of Acting Minister of Healthcare of Kazakhstan of September 9, 2011 № 593 “On Approval of the Republican medicinal form” (in Russian).
10. The Pursuit of Responsible Use of Medicines: Sharingand Learning from Country еxperiences. 2012. Available at: http://apps.who.int (accessed March 3, 2017).
11. Ola A. Akl, Azza A. El Mahalli, Ahmed Awad Elkahky, Abdallah Mohamed Salem. WHO/INRUD drug use indicators at primary healthcare centers in Alexandria, Egypt. J. of Taibah University Medical Sciences. 2014; 9(1): 54–64.
12. Guidance on international nonproprietary names (INN). Available at: http://www.who.int/medicines/services/inn/innguidance/en/ (accessed March 3, 2017).
Review
Views: 21
Email this article 